GENERAL CAPABILITIES
EVENTS
May 18 - 21, 2013
Medpace will attend Digestive Disease Week in Orlando.
May 20 - 22, 2013
Medpace will speak at the Global Clinical Trials Outsourcing Summit in Seoul.
May 22 - 23, 2013
Medpace will speak at Partnerships in Clinical Trials Russia in Istanbul.
May 23 - 24, 2013
Medpace will sponsor the Neurotech Investing & Partnering Conference in St. Regis San Francisco.
May 28 - 31, 2013
Medpace will attend the New Clinical Drug Evalutation Unit Annual Meeting (NCDEU) in Hollywood.
May 29 - 30, 2013
Medpace will attend the New York Biotechnology Association (NYBA) Annual Meeting in New York City.
May 31 - June 4, 2013
Medpace will exhibit at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
June 2 - 5, 2013
Medpace will attend the 81st Congress of the European Atherosclerosis Society in Lyon.
June 12 - 13, 2013
Medpace will exhibit at Outsourcing in Clinical Trials: Medical Devices & Diagnostics in St. Paul.
June 12 - 13, 2013
Medpace will attend Anglonordic Medtech Conference II and Anglonordic Biotech Conference X in London.
June 21 - 25, 2013
Medpace will exhibit at the American Diabetes Association's 73rd Scientific Sessions in Chicago.
June 23 - 27, 2013
Medpace will exhibit at the DIA Annual Meeting in Boston.
July 17 - 18, 2013
Medpace will exhibit at Clinical Operations in Oncology Trials USA in Boston.
Request a Meeting
VIEW ALL EVENTS
Medpace draws on both internal and external resources for its leadership and direction. Currently serving on the Board of Directors are:
August J. Troendle, MD
President and CEO, Medpace, Inc.
Chairman
Stephen Murray
President and Chief Executive Officer, CCMP Capital Advisors, LLC, New York
Kevin O'Brien
Managing Director, CCMP Capital Advisors, LLC, New York
Ryan Anderson
Principal, CCMP Capital Advisors, LLC, New York
Neal McCarthy, JD
CEO, Fairmount Partners, an investment banking and capital advisory firm
Fred B. Davenport, Jr., JD, MBA
Partner of the law firm Murchison, Taylor & Gibson
David Orloff, MD
Senior Vice President, Medical and Regulatory Affairs
Alan W. Milinazzo
CEO, Orthofix Inc.
David W. Gryska
Interim CEO, Myrexis Inc.
Officers
August J. Troendle, MD
President
Jesse Geiger, BBA, CPA
Treasurer
Stephen Ewald, JD
Secretary